ipheral blood smear and rapid confirmatory laboratory testing,PEX may be avoided in patients presenting with severecobalamin deficiency mimicking TTP.Clinicians should be aware of unusual clinical presentationsof cobalamin deficiency masquerading as a seriousmicroangiopathic hemolysis. <strong>The</strong> prompt recognition, diagnosis,and treatment of cobalamin deficiency is vital becausetherapy is safe, inexpensive, and corrects hematologic abnormalitieswhile bringing about a complete or partial correctionof the neuropsychiatric abnormalities in the majority of patients.REFERENCES1. Stabler SP, Allen RH, et al. Clinical spectrum and diagnosis of cobalamindeficiency. Blood 1990;76:871-81.2. Andres E, Affenberger S, et al. Current hematological findings in cobalamindeficiency. Clin Lab Haematol 2006;28:50-6.3. Howard MA, Williams LA, et al. Complications of plasma exchange in patientstreated for clinically suspected thrombotic thrombocytopenic purpurahemolyticuremic syndrome. Transfusion 2006;46:154-6.Samir Dalia, MD, is a resident in internal medicine.Cannon Milani, MD, is a Fellow in Hematology/Oncology.Jorge Castillo MD, is Assistant Professor of Medicine, Departmentof Hematology/Oncology.Anthony Mega,MD, is Associate Professor of Medicine (Clinical),Department of Hematology/Oncology.Fred J Schiffman, MD, is Professor of Medicine, Departmentof Hematology/Oncology.All are at the <strong>The</strong> Warren Alpert <strong>Medical</strong> School of BrownUniversity.Disclosure of Financial Interests<strong>The</strong> authors have no financial interests to disclose.CORRESPONDENCESamir Dalia, MD<strong>The</strong> Miriam Hospital164 Summit Ave<strong>Providence</strong>, RI 02906Phone: (401) 444-4000e-mail:sdalia@lifespan.orgDecember 2009Dear Colleague,This past summer marked a historic victory for antitobaccoadvocates. On June 22, 2009, President Obamasigned into law the new Family Smoking Prevention andTobacco Control Act giving the U.S. Food and Drug Administration(FDA) the authority to regulate tobaccoproducts and stop the harmful practice of marketing tobaccoto children. This law will help significantly reducethe number of children who start to use tobacco, the numberof adults who continue to use tobacco, and the numberof people who die as a result.While this is all good news, it is evident that the FamilySmoking Prevention and Tobacco Control Act cannot byitself put an end to tobacco use. Its intent is to complement,not replace, the successful work that we have beendoing over the years to educate our children about the importanceof being tobacco-free. Interestingly enough, inlate August, major tobacco manufacturers filed suit to overturnportions of the new law, specifically the restrictions onadvertising, marketing and labeling of tobacco products.Since there is more that can be done, the <strong>Rhode</strong> <strong>Island</strong><strong>Medical</strong> <strong>Society</strong> would welcome your support of ourTar Wars <strong>Rhode</strong> <strong>Island</strong> Program, the national tobaccofreeeducational program developed by the AmericanAcademy of Family Physicians. We are looking for physicianpresenters to volunteer to talk with students aboutthe dangers of tobacco use. <strong>The</strong> program involves teachingan hour-long lesson to the students (RIMS providesyou all materials); and then returning to the school to judgea half-hour poster contest. <strong>The</strong> Tar Wars flyer providesfurther details about the Tar Wars program as well as detailsabout the Family Smoking Prevention and TobaccoControl Act. You can also go to www.tarwars.org for moreinformation.If you are interested, please contact Catherine Nortonat 528-3286 or cnorton@rimed.org. We anticipate schoolpresentations to be scheduled during the months of January,February, and March 2010. We also have availablefor your use, “How to Present Tar Wars Guidelines.”Thank you for your support!Sincerely,Arthur A. Frazzano, MDPast PresidentChair, Tar Wars <strong>Rhode</strong> <strong>Island</strong>Tar Wars, a national tobacco-free educational program developedby the American Academy of Family Physicians, iscoordinated locally by the <strong>Rhode</strong> <strong>Island</strong> <strong>Medical</strong> <strong>Society</strong>, the<strong>Rhode</strong> <strong>Island</strong> Academy of Family Physicians, and the <strong>Rhode</strong><strong>Island</strong> Chapter of the American Academy of Pediatrics.26MEDICINE & HEALTH/RHODE ISLAND
THE WARREN ALPERT MEDICAL SCHOOLOF BROWN UNIVERSITYDivision of GeriatricsDepartment of MedicineGERIATRICS FOR THEPRACTICING PHYSICIANSudden Cardiac Death and Implantable CardioverterDefibrillations (ICD) and the Older AdultSudden cardiac arrest (SCA) usually results from a hemodynamicallyunstable heart rhythm-ventricular fibrillation or ventriculartachycardia. Failure or absence of resuscitation results insudden cardiac death (SCD). <strong>The</strong>re are 450,000 cases of SCDannually in the United States. Rate of survival following SCAhas not changed over the past three decades. 1 Survival afterhospital discharge, however, has improved, partly due to thedevelopment of implantable cardioverter defibrillators (ICDs).In 2005, the <strong>Center</strong>s for Medicaid and Medicare Services estimatedthat 500,000 Medicare beneficiaries were candidates forICD placement. 2 ICD prescription in elderly patients entailsparticular considerations, given common co-morbidities andhigher rates of non-cardiac mortality. ICD implantation shouldnot be regarded as routine in elders; each case should be consideredindividually. Geriatricians and other primary care physiciansplay a key role in the judicious selection of candidates forthis potentially life-saving therapy.RISK OF SCD IN ELDERLY<strong>The</strong> prevalence of coronary artery disease (CAD) increaseswith age, along with risk of SCD. <strong>The</strong> proportion of CADdeaths attributed to SCD, however, decreases with age. In theFramingham study, 62% in men aged 45-54 years old whodied of CAD experienced SCD. 3 This percentage fell to 58%in men aged 55-64 years and to 42% in men aged 65-74 years.Congestive heart failure is responsible for a higher proportionof deaths in the elderly population. Advanced age, however, isassociated with a poor outcome following cardiac arrest. In areview of 5,882 cases of out-of-hospital cardiac arrest, octogenariansexperienced a hospital discharge rate of 9%, comparedto 19% in a younger group. 4 In a second series of 12,000patients treated by emergency medical service personnel forSCA, every one-year increase in age was associated with a significantlylower likelihood of survival. 1Omar Hyder, MD, and Ohad Ziv, MDQuality Partners of RIEDITED BY ANA TUYA FULTON, MDINDICATIONS FOR ICD PRESCRIPTIONOver the past two decades, studies identified ICDs as an effectiveprevention strategy of SCD. In survivors of SCA, ICDs arethe secondary prevention strategy of choice. 5,6 Patients at highriskalso benefit from prophylactic ICD implantation. <strong>The</strong>MADIT II and MUSTT studies demonstrated a survival benefitin patients with reduced ejection fraction (